Trials / Completed
CompletedNCT00328965
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
An Open Label, Multi-centre, Single Arm Phase IV Study to Evaluate the Antihypertensive Effect of Lacidipine in Mild to Moderate Essential Hypertension Patients With Type 2 Diabetes in Korea
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lacidipine | Lacidipine 2, 4, 6mg |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2006-05-24
- Last updated
- 2010-08-16
Source: ClinicalTrials.gov record NCT00328965. Inclusion in this directory is not an endorsement.